Valion Bio, Inc. CORRESP, filed Apr 13, 2026: filename1.htm
Tivic Health Systems, Inc.
1305 E. Houston Street, Building 1, Suite 311
San Antonio, TX 78205
(888) 276-6888
|
April 13, 2026 VIA EDGAR
United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549
|
| Re: | Tivic Health Systems, Inc. |
Registration Statement on Form S-1
File No. 333-295029
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Tivic Health Systems, Inc., a Delaware corporation (the “Registrant”), hereby respectfully requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-295029), to become effective on Wednesday, April 15, 2026, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands that the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
|
Very truly yours,
Tivic Health Systems, Inc.
By: /s/ Michael K. Handley Name: Michael K. Handley Title: Chief Executive Officer
|
cc: Christopher L. Tinen, Snell & Wilmer L.L.P.